What is a stock summary page? Click here for an overview.
Business Description
Immatics NV
NAICS : 541713
SIC : 2833
ISIN : NL0015285941
Share Class Description:
IMTX: Ordinary SharesDescription
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 30.61 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.82 | |||||
| Beneish M-Score | 0.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.6 | |||||
| 3-Year EBITDA Growth Rate | 38.8 | |||||
| 3-Year EPS without NRI Growth Rate | 11.7 | |||||
| 3-Year FCF Growth Rate | 57.5 | |||||
| 3-Year Book Growth Rate | 19.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.29 | |||||
| 9-Day RSI | 43.44 | |||||
| 14-Day RSI | 44.51 | |||||
| 3-1 Month Momentum % | -38.31 | |||||
| 6-1 Month Momentum % | -62.88 | |||||
| 12-1 Month Momentum % | -61.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.98 | |||||
| Quick Ratio | 3.98 | |||||
| Cash Ratio | 3.81 | |||||
| Days Sales Outstanding | 7.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | -32.87 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -57.59 | |||||
| Net Margin % | -48 | |||||
| FCF Margin % | -38.4 | |||||
| ROE % | -16.99 | |||||
| ROA % | -9.96 | |||||
| ROIC % | -45.1 | |||||
| 3-Year ROIIC % | -25.62 | |||||
| ROC (Joel Greenblatt) % | -80.03 | |||||
| ROCE % | -11.23 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.7 | |||||
| PB Ratio | 1.1 | |||||
| Price-to-Tangible-Book | 1.1 | |||||
| EV-to-EBIT | -1.12 | |||||
| EV-to-EBITDA | -1.46 | |||||
| EV-to-Revenue | 0.45 | |||||
| EV-to-FCF | -1.93 | |||||
| Price-to-GF-Value | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 1.32 | |||||
| Price-to-Net-Cash | 1.42 | |||||
| Earnings Yield (Greenblatt) % | -89.29 | |||||
| FCF Yield % | -8.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Immatics NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 126.565 | ||
| EPS (TTM) ($) | -0.675 | ||
| Beta | 1.02 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 39.4 | ||
| 14-Day RSI | 44.51 | ||
| 14-Day ATR ($) | 0.311811 | ||
| 20-Day SMA ($) | 4.69 | ||
| 12-1 Month Momentum % | -61.27 | ||
| 52-Week Range ($) | 4.06 - 13.77 | ||
| Shares Outstanding (Mil) | 121.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immatics NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immatics NV Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immatics NV Frequently Asked Questions
What is Immatics NV(IMTX)'s stock price today?
The current price of IMTX is $4.52. The 52 week high of IMTX is $13.77 and 52 week low is $4.06.
When is next earnings date of Immatics NV(IMTX)?
The next earnings date of Immatics NV(IMTX) is 2025-05-14 Est..
Does Immatics NV(IMTX) pay dividends? If so, how much?
Immatics NV(IMTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers